Eton Pharmaceuticals (ETON) Change in Receivables (2020 - 2025)

Eton Pharmaceuticals has disclosed Change in Receivables across 6 years of filings, most recently posting -$1.3 million for Q4 2025.

• In Q4 2025, Change in Receivables fell 241.11% year-over-year to -$1.3 million; the TTM figure through Dec 2025 stood at $6.4 million (up 105.13% YoY), while the FY2025 annual figure was $6.4 million, up 105.13% from the prior year.
• Change in Receivables came in at -$1.3 million for Q4 2025 at Eton Pharmaceuticals, up from -$1.4 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $11.0 million in Q1 2025 to a low of -$4.7 million in Q1 2022.
• Average Change in Receivables over 5 years is $643850.0, with a median of $303000.0 recorded in 2021.
• Year-over-year, Change in Receivables surged 10495.83% in 2021 and sank 1955.16% in 2022.
• Over 5 years, Change in Receivables stood at $5.1 million in 2021, then slumped by 93.04% to $354000.0 in 2022, then sank by 123.73% to -$84000.0 in 2023, then soared by 1217.86% to $939000.0 in 2024, then plunged by 241.11% to -$1.3 million in 2025.
• Per Business Quant data, the three most recent Change in Receivables figures were -$1.3 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.9 million in Q2 2025.